- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Benign Prostatic Hyperplasia (BPH) Treatment Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Benign Prostatic Hyperplasia (BPH) Treatment Devices size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Benign Prostatic Hyperplasia (BPH) Treatment Devices market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Benign Prostatic Hyperplasia (BPH) Treatment Devices market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Surgical Treatment
Minimally Invasive Treatment
Laser Treatment
Other
Market segment by Application can be divided into
Fertility Clinics
Hospitals
Others
The key market players for global Benign Prostatic Hyperplasia (BPH) Treatment Devices market are listed below:
Advin Urology
Biolitec
Boston Scientific Corporation
CONMED
Convergent Laser Technologies
CoreTherm Medical, Inc. (ProstaLund)
HistoSonics, Inc.
JenaSurgical GmbH
KARL STORZ
LISA Laser Products GmbH
Lumenis Ltd.
Medifocus, Inc.
Endo International
Medtronic
Siemens
Olympus
Urologix
NeoTract
Urotech
Baxter International
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Benign Prostatic Hyperplasia (BPH) Treatment Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Benign Prostatic Hyperplasia (BPH) Treatment Devices, with price, sales, revenue and global market share of Benign Prostatic Hyperplasia (BPH) Treatment Devices in 2018 and 2019.
Chapter 3, the Benign Prostatic Hyperplasia (BPH) Treatment Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Benign Prostatic Hyperplasia (BPH) Treatment Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Benign Prostatic Hyperplasia (BPH) Treatment Devices market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Benign Prostatic Hyperplasia (BPH) Treatment Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Surgical Treatment
1.2.3 Minimally Invasive Treatment
1.2.4 Laser Treatment
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Fertility Clinics
1.3.3 Hospitals
1.3.4 Others
1.4 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size & Forecast
1.4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Value (2016-2026))
1.4.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Volume (2016-2026)
1.4.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Type (2016-2026) & (US$/Unit)
1.5 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity Analysis
1.5.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Total Production Capacity (2016-2026)
1.5.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Drivers
1.6.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Restraints
1.6.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Trends Analysis
2 Manufacturers Profiles
2.1 Advin Urology
2.1.1 Advin Urology Details
2.1.2 Advin Urology Major Business
2.1.3 Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
2.1.4 Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Biolitec
2.2.1 Biolitec Details
2.2.2 Biolitec Major Business
2.2.3 Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
2.2.4 Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Boston Scientific Corporation
2.3.1 Boston Scientific Corporation Details
2.3.2 Boston Scientific Corporation Major Business
2.3.3 Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
2.3.4 Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 CONMED
2.4.1 CONMED Details
2.4.2 CONMED Major Business
2.4.3 CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
2.4.4 CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Convergent Laser Technologies
2.5.1 Convergent Laser Technologies Details
2.5.2 Convergent Laser Technologies Major Business
2.5.3 Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
2.5.4 Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 CoreTherm Medical, Inc. (ProstaLund)
2.6.1 CoreTherm Medical, Inc. (ProstaLund) Details
2.6.2 CoreTherm Medical, Inc. (ProstaLund) Major Business
2.6.3 CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
2.6.4 CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 HistoSonics, Inc.
2.7.1 HistoSonics, Inc. Details
2.7.2 HistoSonics, Inc. Major Business
2.7.3 HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
2.7.4 HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 JenaSurgical GmbH
2.8.1 JenaSurgical GmbH Details
2.8.2 JenaSurgical GmbH Major Business
2.8.3 JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
2.8.4 JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 KARL STORZ
2.9.1 KARL STORZ Details
2.9.2 KARL STORZ Major Business
2.9.3 KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
2.9.4 KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 LISA Laser Products GmbH
2.10.1 LISA Laser Products GmbH Details
2.10.2 LISA Laser Products GmbH Major Business
2.10.3 LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
2.10.4 LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Lumenis Ltd.
2.11.1 Lumenis Ltd. Details
2.11.2 Lumenis Ltd. Major Business
2.11.3 Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
2.11.4 Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Medifocus, Inc.
2.12.1 Medifocus, Inc. Details
2.12.2 Medifocus, Inc. Major Business
2.12.3 Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
2.12.4 Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Endo International
2.13.1 Endo International Details
2.13.2 Endo International Major Business
2.13.3 Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
2.13.4 Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Medtronic
2.14.1 Medtronic Details
2.14.2 Medtronic Major Business
2.14.3 Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
2.14.4 Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Siemens
2.15.1 Siemens Details
2.15.2 Siemens Major Business
2.15.3 Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
2.15.4 Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Olympus
2.16.1 Olympus Details
2.16.2 Olympus Major Business
2.16.3 Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
2.16.4 Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Urologix
2.17.1 Urologix Details
2.17.2 Urologix Major Business
2.17.3 Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
2.17.4 Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 NeoTract
2.18.1 NeoTract Details
2.18.2 NeoTract Major Business
2.18.3 NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
2.18.4 NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.19 Urotech
2.19.1 Urotech Details
2.19.2 Urotech Major Business
2.19.3 Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
2.19.4 Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.20 Baxter International
2.20.1 Baxter International Details
2.20.2 Baxter International Major Business
2.20.3 Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
2.20.4 Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Manufacturer
3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Benign Prostatic Hyperplasia (BPH) Treatment Devices
3.4 Market Concentration Rate
3.4.1 Top 3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturer Market Share
3.4.2 Top 6 Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturer Market Share
3.5 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Region
4.1.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Volume by Region (2016-2026)
4.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Region (2016-2026)
4.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (2016-2026)
4.3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (2016-2026)
4.4 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (2016-2026)
4.5 South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (2016-2026)
4.6 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Volume by Type (2016-2026)
5.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Type (2016-2026)
5.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Volume by Application (2016-2026)
6.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Application (2016-2026)
6.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2016-2026)
7.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2026)
7.3 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Country
7.3.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Volume by Country (2016-2026)
7.3.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2016-2026)
8.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2026)
8.3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Country
8.3.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Volume by Country (2016-2026)
8.3.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2016-2026)
9.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2026)
9.3 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Region
9.3.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2016-2026)
10.2 South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2026)
10.3 South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Country
10.3.1 South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Volume by Country (2016-2026)
10.3.2 South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2016-2026)
11.2 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2026)
11.3 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Country
11.3.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Typical Distributors
12.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Type, (USD Million), 2021-2026
Table 2. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Application, (USD Million), 2021-2026
Table 3. Advin Urology Basic Information, Manufacturing Base and Competitors
Table 4. Advin Urology Major Business
Table 5. Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
Table 6. Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Biolitec Basic Information, Manufacturing Base and Competitors
Table 8. Biolitec Major Business
Table 9. Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
Table 10. Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 12. Boston Scientific Corporation Major Business
Table 13. Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
Table 14. Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. CONMED Basic Information, Manufacturing Base and Competitors
Table 16. CONMED Major Business
Table 17. CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
Table 18. CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Convergent Laser Technologies Basic Information, Manufacturing Base and Competitors
Table 20. Convergent Laser Technologies Major Business
Table 21. Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
Table 22. Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. CoreTherm Medical, Inc. (ProstaLund) Basic Information, Manufacturing Base and Competitors
Table 24. CoreTherm Medical, Inc. (ProstaLund) Major Business
Table 25. CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
Table 26. CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. HistoSonics, Inc. Basic Information, Manufacturing Base and Competitors
Table 28. HistoSonics, Inc. Major Business
Table 29. HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
Table 30. HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. JenaSurgical GmbH Basic Information, Manufacturing Base and Competitors
Table 32. JenaSurgical GmbH Major Business
Table 33. JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
Table 34. JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. KARL STORZ Basic Information, Manufacturing Base and Competitors
Table 36. KARL STORZ Major Business
Table 37. KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
Table 38. KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. LISA Laser Products GmbH Basic Information, Manufacturing Base and Competitors
Table 40. LISA Laser Products GmbH Major Business
Table 41. LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
Table 42. LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Lumenis Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Lumenis Ltd. Major Business
Table 45. Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
Table 46. Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Medifocus, Inc. Basic Information, Manufacturing Base and Competitors
Table 48. Medifocus, Inc. Major Business
Table 49. Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
Table 50. Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Endo International Basic Information, Manufacturing Base and Competitors
Table 52. Endo International Major Business
Table 53. Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
Table 54. Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Medtronic Basic Information, Manufacturing Base and Competitors
Table 56. Medtronic Major Business
Table 57. Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
Table 58. Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Siemens Basic Information, Manufacturing Base and Competitors
Table 60. Siemens Major Business
Table 61. Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
Table 62. Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Olympus Basic Information, Manufacturing Base and Competitors
Table 64. Olympus Major Business
Table 65. Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
Table 66. Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Urologix Basic Information, Manufacturing Base and Competitors
Table 68. Urologix Major Business
Table 69. Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
Table 70. Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. NeoTract Basic Information, Manufacturing Base and Competitors
Table 72. NeoTract Major Business
Table 73. NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
Table 74. NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Urotech Basic Information, Manufacturing Base and Competitors
Table 76. Urotech Major Business
Table 77. Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
Table 78. Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Baxter International Basic Information, Manufacturing Base and Competitors
Table 80. Baxter International Major Business
Table 81. Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Services
Table 82. Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Manufacturer (2019-2021e) & (K Units)
Table 84. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 85. Market Position of Manufacturers in Benign Prostatic Hyperplasia (BPH) Treatment Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 86. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity by Company, (K Units): 2020 VS 2021
Table 87. Head Office and Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Site of Key Manufacturer
Table 88. Benign Prostatic Hyperplasia (BPH) Treatment Devices New Entrant and Capacity Expansion Plans
Table 89. Benign Prostatic Hyperplasia (BPH) Treatment Devices Mergers & Acquisitions in the Past Five Years
Table 90. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2016-2021e) & (K Units)
Table 91. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2021-2026) & (K Units)
Table 92. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Region (2016-2021e) & (USD Million)
Table 93. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Region (2021-2026) & (USD Million)
Table 94. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2016-2021e) & (K Units)
Table 95. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2021-2026) & (K Units)
Table 96. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Type (2016-2021e) & (USD Million)
Table 97. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Type (2021-2026) & (USD Million)
Table 98. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Type (2016-2021e) & (US$/Unit)
Table 99. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Type (2021-2026) & (US$/Unit)
Table 100. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2021e) & (K Units)
Table 101. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2021-2026) & (K Units)
Table 102. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Application (2016-2021e) & (USD Million)
Table 103. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Application (2021-2026) & (USD Million)
Table 104. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Application (2016-2021e) & (US$/Unit)
Table 105. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Application (2021-2026) & (US$/Unit)
Table 106. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2016-2021e) & (K Units)
Table 107. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2021-2026) & (K Units)
Table 108. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2016-2021e) & (USD Million)
Table 109. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2021-2026) & (USD Million)
Table 110. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2016-2021e) & (K Units)
Table 111. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2021-2026) & (K Units)
Table 112. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2021e) & (K Units)
Table 113. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2021-2026) & (K Units)
Table 114. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2016-2021e) & (K Units)
Table 115. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2021-2026) & (K Units)
Table 116. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2016-2021e) & (USD Million)
Table 117. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2021-2026) & (USD Million)
Table 118. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2016-2021e) & (K Units)
Table 119. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2021-2026) & (K Units)
Table 120. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2021e) & (K Units)
Table 121. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2021-2026) & (K Units)
Table 122. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2016-2021e) & (K Units)
Table 123. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2021-2026) & (K Units)
Table 124. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Region (2016-2021e) & (USD Million)
Table 125. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Region (2021-2026) & (USD Million)
Table 126. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2016-2021e) & (K Units)
Table 127. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2021-2026) & (K Units)
Table 128. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2021e) & (K Units)
Table 129. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2021-2026) & (K Units)
Table 130. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2016-2021e) & (K Units)
Table 131. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2021-2026) & (K Units)
Table 132. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2016-2021e) & (USD Million)
Table 133. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2021-2026) & (USD Million)
Table 134. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2016-2021e) & (K Units)
Table 135. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2021-2026) & (K Units)
Table 136. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2021e) & (K Units)
Table 137. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2021-2026) & (K Units)
Table 138. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2016-2021e) & (K Units)
Table 139. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2021-2026) & (K Units)
Table 140. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2016-2021e) & (USD Million)
Table 141. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2021-2026) & (USD Million)
Table 142. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2016-2021e) & (K Units)
Table 143. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2021-2026) & (K Units)
Table 144. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2021e) & (K Units)
Table 145. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2021-2026) & (K Units)
Table 146. Direct Channel Pros & Cons
Table 147. Indirect Channel Pros & Cons
Table 148. Benign Prostatic Hyperplasia (BPH) Treatment Devices Typical Distributors
Table 149. Benign Prostatic Hyperplasia (BPH) Treatment Devices Typical Customers
List of Figures
Figure 1. Benign Prostatic Hyperplasia (BPH) Treatment Devices Picture
Figure 2. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type in 2020
Figure 3. Surgical Treatment
Figure 4. Minimally Invasive Treatment
Figure 5. Laser Treatment
Figure 6. Other
Figure 7. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application in 2020
Figure 8. Fertility Clinics
Figure 9. Hospitals
Figure 10. Others
Figure 11. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 12. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (2016-2026) & (K Units)
Figure 14. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Type (2016-2026) & (US$/Unit)
Figure 15. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity (2016-2026) & (K Units)
Figure 16. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity by Geographic Region: 2020 VS 2021
Figure 17. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Drivers
Figure 18. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Restraints
Figure 19. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Trends
Figure 20. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Manufacturer in 2020
Figure 21. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Manufacturer in 2020
Figure 22. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. Top 3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturer (Revenue) Market Share in 2020
Figure 24. Top 6 Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturer (Revenue) Market Share in 2020
Figure 25. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region (2016-2026)
Figure 26. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Region (2016-2026)
Figure 27. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (2016-2026) & (USD Million)
Figure 28. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (2016-2026) & (USD Million)
Figure 29. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (2016-2026) & (USD Million)
Figure 30. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (2016-2026) & (USD Million)
Figure 31. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (2016-2026) & (USD Million)
Figure 32. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2016-2026)
Figure 33. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Type (2016-2026)
Figure 34. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Type (2016-2026) & (US$/Unit)
Figure 35. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2016-2026)
Figure 36. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Application (2016-2026)
Figure 37. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Application (2016-2026) & (US$/Unit)
Figure 38. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2016-2026)
Figure 39. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2016-2026)
Figure 40. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country (2016-2026)
Figure 41. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Country (2016-2026)
Figure 42. United States Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2016-2026)
Figure 46. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2016-2026)
Figure 47. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country (2016-2026)
Figure 48. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Country (2016-2026)
Figure 49. Germany Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Region (2016-2026)
Figure 58. China Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2016-2026)
Figure 65. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2016-2026)
Figure 66. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country (2016-2026)
Figure 67. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2016-2026)
Figure 71. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Egypt Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. South Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
